Correlation Between XOMA and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XOMA and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XOMA and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XOMA Corporation and Allovir, you can compare the effects of market volatilities on XOMA and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XOMA with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of XOMA and Allovir.

Diversification Opportunities for XOMA and Allovir

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between XOMA and Allovir is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding XOMA Corp. and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and XOMA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XOMA Corporation are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of XOMA i.e., XOMA and Allovir go up and down completely randomly.

Pair Corralation between XOMA and Allovir

Assuming the 90 days horizon XOMA Corporation is expected to generate 0.07 times more return on investment than Allovir. However, XOMA Corporation is 14.56 times less risky than Allovir. It trades about 0.08 of its potential returns per unit of risk. Allovir is currently generating about -0.3 per unit of risk. If you would invest  2,539  in XOMA Corporation on September 17, 2024 and sell it today you would earn a total of  11.00  from holding XOMA Corporation or generate 0.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

XOMA Corp.  vs.  Allovir

 Performance 
       Timeline  
XOMA 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in XOMA Corporation are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, XOMA is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Allovir 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

XOMA and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with XOMA and Allovir

The main advantage of trading using opposite XOMA and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XOMA position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
The idea behind XOMA Corporation and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets